Biotricity Profit Margin

The latest profit margin for BTCY is -17.72% as of March 2026. That compares with -85.32% in the prior-year period — up 79.2% year over year. That is below the Healthcare sector average of 15.29%. Investors often review this figure alongside Biotricity's historical trend and sector peers before judging valuation or financial health.

Over the past year, BTCY's profit margin moved from -85.32% to -17.72% — a 79.2% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Biotricity's valuation or profitability profile.

Against Healthcare companies, BTCY currently prints -17.72% for profit margin, while the sector average sits near 15.29%. That is roughly 215.9% below the sector mean. Large gaps often invite a closer look at Biotricity's growth, margins, and balance sheet.

Profit Margin shows how effectively Biotricity converts resources into returns. At -17.72%, BTCY may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -85.32% in the prior-year period — up 79.2% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting BTCY's profit margin (-17.72%), review year-over-year change from -85.32%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.